Search Results - "Hickey, Adam"

Between Two Spheres: Comparing State and Federal Approaches to the Right to Privacy and Prohibitions Against Sodomy.

Authors: Hickey, Adam

Source: Yale Law Journal. Jan2002, Vol. 111 Issue 4, p993. 36p.

Diagnostic Potential of ⁶⁸Ga-NeoB PET/CT with Estrogen Receptor– and Progesterone Receptor–Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease.

Authors: Sabahi, Zahra Nguyen, Andrew Wong, Keith et al.

Source: Journal of Nuclear Medicine. May2025, Vol. 66 Issue 5, p700-706. 7p.

Development of a Visually Calculated SUVmean (HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to ¹⁷⁷Lu-PSMA Therapy: Comparison with Quantitative SUVmean and Patient Outcomes.

Authors: Swiha, Mina Papa, Nathan Sabahi, Zahra et al.

Source: Journal of Nuclear Medicine. Jun2024, Vol. 65 Issue 6, p904-908. 5p.

Diagnostic value of ⁶⁸Ga‐DOTATATE PET‐CT imaging for staging of ER⁺/PR⁺ HER2‐ breast cancer patients with metastatic disease: Comparison with conventional imaging with bone scan, diagnostic CT and ¹⁸F‐FDG PET‐CT in a prospective pilot trial

Authors: Nguyen, Andrew Fullard, Karen Sheehan‐Dare, Gemma et al.

Source: Journal of Medical Imaging & Radiation Oncology. Sep2022, Vol. 66 Issue 6, p731-737. 7p.

¹⁷⁷Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing ¹⁷⁷Lu-PSMA-I&T Therapy.

Authors: John, Nikeith Pathmanandavel, Sarennya Crumbaker, Megan et al.

Source: Journal of Nuclear Medicine. Mar2023, Vol. 64 Issue 3, p410-415. 6p.

Evaluation of ¹⁷⁷Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective ¹⁷⁷Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).

Authors: Pathmanandavel, Sarennya Crumbaker, Megan Bao Ho et al.

Source: Journal of Nuclear Medicine. Feb2023, Vol. 64 Issue 2, p221-226. 6p.

¹⁷⁷Lu-PSMA SPECT Quantitation at 6 Weeks (dose 2) Predicts Short Progression Free Survival for Patients Undergoing Lu PSMA I&T Therapy.

Authors: John, Nikeith Pathmanandavel, Sarennya Crumbaker, Megan et al.

Source: Journal of Nuclear Medicine. Oct2022, Vol. 63 Issue 10, p1-25. 25p.

Evaluation of ¹⁷⁷Lu-PSMA SPECT Quantitation as a Response Biomarker within a Prospective ¹⁷⁷Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).

Authors: Pathmanandavel, Sarennya Crumbaker, Megan Ho, Bao et al.

Source: Journal of Nuclear Medicine. Oct2022, Vol. 63 Issue 10, p1-27. 27p.

Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial ⁶⁸Ga-PSMA-11 PET in Men with Hormone-Sensitive and Castrate-Resistant Prostate Cancer Commencing Androgen Blockade.

Authors: Emmett, Louise Yin, Charlotte Crumbaker, Megan et al.

Source: Journal of Nuclear Medicine. Jul2019, Vol. 60 Issue 7, p950-954. 5p. 3 Color Photographs, 2 Charts, 2 Graphs.

Dual-time-point ¹⁸F-FDG-PET/CT imaging in the assessment of suspected malignancy.

Authors: Wai-Ling Chan Ramsay, Stuart C. Szeto, Edwin R. et al.

Source: Journal of Medical Imaging & Radiation Oncology. Aug2011, Vol. 55 Issue 4, p379-390. 12p. 1 Color Photograph.

Prospective Comparison of ¹⁸F-Fluoromethylcholine Versus ⁶⁸Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.

Authors: Morigi, Joshua J. Stricker, Phillip D. van Leeuwen, Pim J. et al.

Source: Journal of Nuclear Medicine. Aug2015, Vol. 56 Issue 8, p1185-1190. 6p. 3 Color Photographs, 2 Charts, 3 Graphs.

68Ga-HBEDD PSMA-11 PET/CT staging prior to radical prostatectomy in prostate cancer patients: Diagnostic and predictive value for the biochemical response to surgery.

Authors: Nandurkar, Rohan van leeuwen, Pimmeke Stricker, Phillip et al.

Source: British Journal of Radiology. Mar2019, Vol. 92 Issue 1095, pN.PAG-N.PAG. 1p.

Diagnostic Potential of ⁶⁸Ga-NeoB PET/CT with Estrogen Receptor- and Progesterone Receptor-Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease.

Authors: Sabahi Z Nguyen A Wong K et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2025 May 01; Vol. 66 (5), pp. 700-706. Date of Electronic Publication: 2025 May 01.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Development of a Visually Calculated SUVmean (HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to ¹⁷⁷Lu-PSMA Therapy: Comparison with Quantitative SUVmean and Patient Outcomes.

Authors: Swiha M Papa N Sabahi Z et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Jun 03; Vol. 65 (6), pp. 904-908. Date of Electronic Publication: 2024 Jun 03.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT).

Authors: Emmett L John N Pathmanandavel S et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Mar 01; Vol. 15, pp. 17588359231156392. Date of Electronic Publication: 2023 Mar 01 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

¹⁷⁷Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing ¹⁷⁷Lu-PSMA-I&T Therapy.

Authors: John N Pathmanandavel S Crumbaker M et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Mar; Vol. 64 (3), pp. 410-415. Date of Electronic Publication: 2022 Sep 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Evaluation of ¹⁷⁷Lu-PSMA-617 SPECT/CT Quantitation as a Response Biomarker Within a Prospective ¹⁷⁷Lu-PSMA-617 and NOX66 Combination Trial (LuPIN).

Authors: Pathmanandavel S Crumbaker M Ho B et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Feb; Vol. 64 (2), pp. 221-226. Date of Electronic Publication: 2022 Aug 25.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial ⁶⁸Ga-PSMA-11 PET in Men with Hormone-Sensitive and Castrate-Resistant Prostate Cancer Commencing Androgen Blockade.

Authors: Emmett L Yin C Crumbaker M et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2019 Jul; Vol. 60 (7), pp. 950-954. Date of Electronic Publication: 2018 Dec 14.

Publication Type: Clinical Trial; Journal Article

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.

Authors: Morigi JJ Stricker PD van Leeuwen PJ et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2015 Aug; Vol. 56 (8), pp. 1185-90. Date of Electronic Publication: 2015 Jun 25.

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Impact of Patient Preparation on the Diagnostic Performance of 18F-FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-analysis.

Authors: Tang R Wang JT Wang L et al.

Source: Clinical nuclear medicine [Clin Nucl Med] 2016 Jul; Vol. 41 (7), pp. e327-39.

Publication Type: Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: Lippincott Country of Publication: United States NLM ID: 7611109 Publication Model: Print Cited Medium: Internet ISSN: 1536-0229 (Electronic) Linking ISSN: 03639762 NLM ISO Abbreviation: Clin Nucl Med Subsets: MEDLINE